Plasma phospholipids n-3 polyunsaturated fatty acid is associated with metabolic syndrome

Molecular Nutrition and Food Research

Volumn 54, Issue 11, 2010, Pages 1628-1635

  Huang, Tao ^a,b   Bhulaidok, Subhachai ^a,b   Cai, Zhenzhen ^a,b   Xu, Tongcheng ^a,b   Xu, Fang ^c   Wahlqvist, Mark L ^a,b,d   Li, Duo ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b APCNS Centre of Nutrition and Food Safety   (China)

^c Convalescent Hospital of PLAAF ^*  (China)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Metabolic syndrome; n 3 polyunsaturated fatty acid; Phospholipids; Total fatty acid

Indexed keywords

BIOLOGICAL MARKER; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CHINA; CROSS-SECTIONAL STUDY; FEEDING BEHAVIOR; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PLASMA; REGRESSION ANALYSIS;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHINA; CROSS-SECTIONAL STUDIES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FOOD HABITS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHOSPHOLIPIDS; PLASMA; REGRESSION ANALYSIS;

EID: 78349257835     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000025     Document Type: Article

References (48)

1. Eckel, R. H., Grundy, S. M., Zimmet, P. Z., The metabolic syndrome. Lancet 2005, 365, 1415-1428.
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285, 2486-2497.
3. Lee, E., Lee, S., Park, Y., n-3 Polyunsaturated fatty acids and trans fatty acids in patients with the metabolic syndrome: a case-control study in Korea. Br. J. Nutr. 2008, 100, 609-614.
4. Sibbitt, W. L., Jr., Brandt, J. R., Johnson, C. R., Maldonado, M. E. et al., The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J. Rheumatol. 2002, 29, 1536-1542.
5. Gu, D., Reynolds, K., Wu, X., Chen, J. et al., Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005, 365, 1398-1405.
6. Zimmet, P., Alberti, K. G., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782-787.
7. Shi, Z., Hu, X., Yuan, B., Hu, G. et al., Coexistence of anaemia and the metabolic syndrome in adults in Jiangsu, China. Asia Pac. J. Clin. Nutr. 2008, 17, 505-513.
8. Cai, Z., Xu, X., Wu, X., Zhou, C., Li, D., Hyperuricemia and the metabolic syndrome in Hangzhou. Asia Pac. J. Clin. Nutr. 2009, 18, 81-87.
9. Esposito, K., Ceriello, A., Giugliano, D., Diet and the metabolic syndrome. Metab. Syndr. Relat. Disord. 2007, 5, 291-296.
10. Feldeisen, S. E., Tucker, K. L., Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl. Physiol. Nutr. Metab. 2007, 32, 46-60.
11. Tulk, H. M., Robinson, L. E., Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome. Metabolism 2009, 58, 1709-1716.
12. Warensjo, E., Riserus, U., Vessby, B., Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005, 48, 1999-2005.
13. Wang, L., Folsom, A. R., Zheng, Z. J., Pankow, J. S., Eckfeldt, J. H., Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 2003, 78, 91-98.
14. Tremblay, A. J., Despres, J. P., Piche, M. E., Nadeau, A. et al., Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism 2004, 53, 310-317.
15. Nigam, A., Frasure-Smith, N., Lesperance, F., Julien, P., Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 264-270.
16. Carpentier, Y. A., Portois, L., Malaisse, W. J., n-3 fatty acids and the metabolic syndrome. Am. J. Clin. Nutr. 2006, 83, 1499S-1504S.
17. Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F. et al., Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 2000, 71, 1085-1094.
18. Huang, T., Wahlqvist, M. L., Xu, T., Xu, A. et al., Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China. Mol. Nutr. Food Res. 2010, 54, S112-S119.
19. Lombardo, Y. B., Chicco, A. G., Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J. Nutr. Biochem. 2006, 17, 1-13.
20. Ebbesson, S. O., Risica, P. M., Ebbesson, L. O., Kennish, J. M., Tejero, M. E., Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int. J. Circumpolar Health 2005, 64, 396-408.
21. Popp-Snijders, C., Schouten, J. A., Heine, R. J., van der Meer, J., van der Veen, E. A., Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res. 1987, 4, 141-147.
22. Friedberg, C. E., Janssen, M. J., Heine, R. J., Grobbee, D. E., Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998, 21, 494-500.
23. Riccardi, G., Giacco, R., Rivellese, A. A., Dietary fat, insulin sensitivity and the metabolic syndrome. Clin. Nutr. 2004, 23, 447-456.
24. Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A. et al., Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol. Rev. 2005, 13, 322-327.
25. Mann, N. J., Li, D., Sinclair, A. J., Dudman, N. P. et al., The effect of diet on plasma homocysteine concentrations in healthy male subjects. Eur. J. Clin. Nutr. 1999, 53, 895-899.
26. Orchard, T. J., Temprosa, M., Goldberg, R., Haffner, S. et al., The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann. Intern. Med. 2005, 142, 611-619.
27. Warensjo, E., Sundstrom, J., Lind, L., Vessby, B., Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am. J. Clin. Nutr. 2006, 84, 442-448.
28. Ebbesson, S. O., Tejero, M. E., Nobmann, E. D., Lopez-Alvarenga, J. C. et al., Fatty acid consumption and metabolic syndrome components: the GOCADAN study. J. Cardiometab. Syndr. 2007, 2, 244-249.
29. Li, D., Yu, X. M., Xie, H. B., Zhang, Y. H. et al., Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76, 293-297.
30. Stettler, R., Ith, M., Acheson, K. J., Decombaz, J. et al., Interaction between dietary lipids and physical inactivity on insulin sensitivity and on intramyocellular lipids in healthy men. Diabetes Care 2005, 28, 1404-1409.
31. Mozaffarian, D., Pischon, T., Hankinson, S. E., Rifai, N. et al., Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 2004, 79, 606-612.
32. Bang, H. O., Dyerberg, J., Nielsen, A. B., Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet 1971, 1, 1143-1145.
33. Salomaa, V., Ahola, I., Tuomilehto, J., Aro, A. et al., Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism 1990, 39, 1285-1291.
34. Borkman, M., Storlien, L. H., Pan, D. A., Jenkins, A. B. et al., The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 1993, 328, 238-244.
35. Truong, H., DiBello, J. R., Ruiz-Narvaez, E., Kraft, P. et al., Does genetic variation in the Delta6-desaturase promoter modify the association between alpha-linolenic acid and the prevalence of metabolic syndrome? Am. J. Clin. Nutr. 2009, 89, 920-925.
36. Mensink, R. P., Zock, P. L., Kester, A. D., Katan, M. B., Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146-1155.
37. Browning, L. M., n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc. Nutr. Soc. 2003, 62, 447-453.
38. Troisi, R., Willett, W. C., Weiss, S. T., Trans-fatty acid intake in relation to serum lipid concentrations in adult men. Am. J. Clin. Nutr. 1992, 56, 1019-1024.
39. Clarke, S. D., Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J. Nutr. 2001, 131, 1129-1132.
40. Klein-Platat, C., Drai, J., Oujaa, M., Schlienger, J. L., Simon, C., Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am. J. Clin. Nutr. 2005, 82, 1178-1184.
41. Holness, M. J., Greenwood, G. K., Smith, N. D., Sugden, M. C., Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the regulation of endogenous glucose production. Endocrinology 2003, 144, 3958-3968.
42. Delarue, J., LeFoll, C., Corporeau, C., Lucas, D., N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod. Nutr. Dev. 2004, 44, 289-299.
43. Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B. et al., Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am. J. Clin. Nutr. 2002, 76, 1007-1015.
44. Tai, E. S., Corella, D., Demissie, S., Cupples, L. A. et al., Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J. Nutr. 2005, 135, 397-403.
45. Garaulet, M., Lee, Y. C., Shen, J., Parnell, L. D. et al., CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids. Am. J. Clin. Nutr. 2009, 90, 1466-1475.
46. Mattei, J., Demissie, S., Tucker, K. L., Ordovas, J. M., Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. J. Nutr. 2009, 139, 2301-2308.
47. Shen, J., Arnett, D. K., Peacock, J. M., Parnell, L. D. et al., Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J. Nutr. 2007, 137, 1846-1851.
48. Phillips, C. M., Goumidi, L., Bertrais, S., Ferguson, J. F. et al., Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am. J. Clin. Nutr. 2009, 90, 1655-1673.